James Chen, CMT is an expert trader, investment adviser, and global market strategist. Khadija Khartit is a strategy, investment, and funding expert, and an educator of fintech and strategic finance ...
The U.S. Food and Drug Administration (FDA) has introduced a new pilot program to prioritize Abbreviated New Drug Applications (ANDAs) for generic drugs that utilize U.S.-based manufacturing and ...
FDA has determined that NRx’s Abbreviated New Drug Application (ANDA) is “substantially complete” and received for review. Assigned GDUFA goal date is July 29, 2026. NRx has applied to FDA for use of ...
Abbreviated new drug application filings have declined to 600 in the financial year 2025 (ending in September) versus 740 in ...
Bionpharma gets US FDA nod for etravirine tablets developed in collaboration with STEERLife: Our Bureau, Bengaluru Tuesday, January 13, 2026, 16:15 Hrs [IST] Bionpharma Inc. has a ...
The FDA approved Evita Solutions’ abbreviated new drug application for mifepristone 200 mg tablets, with the approval taking effect Sept. 30. The product was determined to be bioequivalent and ...
Alembic Pharmaceuticals receives USFDA tentative approval for generic Bosutinib tablets, a cancer treatment drug. ANDA ...
BRISBANE, Calif., Oct. 27, 2025 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (PCRX), the industry leader in its commitment to deliver innovative, non-opioid pain therapies to transform the lives of ...
PharmaTher Holdings Ltd ( ($TSE:PHRM) ) just unveiled an announcement. PharmaTher CEO Fabio Chianelli outlined how 2025 marked a transition from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback